Td Asset Management Inc Alnylam Pharmaceuticals, Inc. Transaction History

Td Asset Management Inc

  • $107 Billion
  • Q3 2024

A detailed history of Td Asset Management Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Td Asset Management Inc holds 488,283 shares of ALNY stock, worth $120 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
488,283
Previous 489,940 0.34%
Holding current value
$120 Million
Previous $119 Million 12.82%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
SELL
$233.81 - $287.01 $387,423 - $475,575
-1,657 Reduced 0.34%
488,283 $134 Million
Q2 2024

Aug 02, 2024
BUY
$143.31 - $247.0 $3.95 Million - $6.82 Million
27,592 Added 5.97%
489,940 $119 Million
Q1 2024

May 08, 2024
SELL
$146.51 - $198.2 $547,507 - $740,673
-3,737 Reduced 0.8%
462,348 $69.1 Million
Q4 2023

Feb 12, 2024
SELL
$151.41 - $196.57 $4.43 Million - $5.76 Million
-29,279 Reduced 5.91%
466,085 $89.2 Million
Q3 2023

Oct 27, 2023
BUY
$170.77 - $211.65 $23.3 Million - $28.8 Million
136,283 Added 37.95%
495,364 $87.7 Million
Q2 2023

Aug 09, 2023
SELL
$185.01 - $212.05 $144,862 - $166,035
-783 Reduced 0.22%
359,081 $68.2 Million
Q1 2023

May 10, 2023
SELL
$182.66 - $235.53 $5.95 Million - $7.67 Million
-32,586 Reduced 8.3%
359,864 $72.1 Million
Q4 2022

Feb 06, 2023
BUY
$185.53 - $241.31 $1.42 Million - $1.84 Million
7,639 Added 1.99%
392,450 $93.3 Million
Q3 2022

Nov 07, 2022
SELL
$138.54 - $232.0 $2.14 Million - $3.59 Million
-15,457 Reduced 3.86%
384,811 $80.6 Million
Q2 2022

Aug 04, 2022
BUY
$120.42 - $169.29 $913,506 - $1.28 Million
7,586 Added 1.93%
400,268 $58.4 Million
Q1 2022

May 10, 2022
SELL
$127.18 - $173.91 $482,139 - $659,292
-3,791 Reduced 0.96%
392,682 $64.1 Million
Q4 2021

Feb 10, 2022
BUY
$159.56 - $209.29 $25.8 Million - $33.9 Million
161,789 Added 68.94%
396,473 $67.2 Million
Q3 2021

Nov 09, 2021
BUY
$169.75 - $207.73 $1.8 Million - $2.2 Million
10,584 Added 4.72%
234,684 $44.3 Million
Q2 2021

Aug 11, 2021
BUY
$128.63 - $176.89 $4.13 Million - $5.67 Million
32,078 Added 16.71%
224,100 $40.1 Million
Q1 2021

May 14, 2021
BUY
$126.83 - $175.69 $2.09 Million - $2.9 Million
16,495 Added 9.4%
192,022 $27.1 Million
Q4 2020

Feb 16, 2021
BUY
$122.97 - $147.0 $993,597 - $1.19 Million
8,080 Added 4.83%
175,527 $22.8 Million
Q3 2020

Nov 10, 2020
BUY
$121.19 - $165.49 $1.2 Million - $1.64 Million
9,887 Added 6.28%
167,447 $24.4 Million
Q2 2020

Aug 13, 2020
BUY
$104.21 - $156.44 $911,108 - $1.37 Million
8,743 Added 5.88%
157,560 $23.3 Million
Q1 2020

May 15, 2020
BUY
$93.12 - $133.99 $1.55 Million - $2.22 Million
16,600 Added 12.56%
148,817 $16.2 Million
Q4 2019

Feb 11, 2020
BUY
$74.51 - $124.23 $1.35 Million - $2.26 Million
18,165 Added 15.93%
132,217 $15.2 Million
Q3 2019

Nov 07, 2019
BUY
$70.9 - $87.82 $1.26 Million - $1.56 Million
17,800 Added 18.49%
114,052 $9.17 Million
Q2 2019

Aug 01, 2019
BUY
$65.86 - $92.79 $245,657 - $346,106
3,730 Added 4.03%
96,252 $6.98 Million
Q1 2019

May 08, 2019
SELL
$72.76 - $93.45 $86,220 - $110,738
-1,185 Reduced 1.26%
92,522 $8.65 Million
Q4 2018

Feb 01, 2019
SELL
$62.67 - $88.33 $835,453 - $1.18 Million
-13,331 Reduced 12.45%
93,707 $6.83 Million
Q3 2018

Nov 01, 2018
SELL
$87.52 - $122.67 $1.68 Million - $2.36 Million
-19,250 Reduced 15.24%
107,038 $9.37 Million
Q2 2018

Jul 31, 2018
SELL
$88.31 - $107.8 $3.76 Million - $4.59 Million
-42,608 Reduced 25.23%
126,288 $12.4 Million
Q1 2018

May 11, 2018
BUY
$115.92 - $148.54 $1.15 Million - $1.48 Million
9,950 Added 6.26%
168,896 $20.1 Million
Q4 2017

Feb 02, 2018
BUY
$114.49 - $139.98 $2.31 Million - $2.82 Million
20,151 Added 14.52%
158,946 $20.2 Million
Q3 2017

Nov 09, 2017
BUY
$72.53 - $118.27 $10.1 Million - $16.4 Million
138,795
138,795 $16.3 Million

Others Institutions Holding ALNY

# of Institutions
643
Shares Held
109M
Call Options Held
1.28M
Put Options Held
1.21M
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $30.2B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email